About US
Contact us
-
Eli Lilly's diabetes strategy doesn't include big staff-up in salesDon't expect Eli Lilly to pump up its sales force as newdiabetes drugsmake their debuts over the next three years. As Lilly Diabetes President Enrique Conterno tellsBloomberg, the company ($LLY) plans2013/9/25
-
Novartis board to shrink executive pay, director saysNovartis board member Pierre Landolt let a couple of things slip in an interview with theBasler Zeitungpublished over the weekend. The first is a bit of a head-scratcher: Landolt would like the new ch2013/9/24
-
Indian drug regulator reaches out to other countries as issues mountThe top drug regulator inIndiahas decided it is time to confer with some of his peers around the world after a run of tough regulatory actions by Western countries against Indian drugmakers. Just last2013/9/24
-
CFDA Vice Minister Teng Jiacai meets Executive Director General of Danish Veterinary and Food AdministrationOn September 18, 2013, Teng Jiacai, Vice Minister of China Food and Drug Administration (CFDA), met with the delegation led by Esben E. Rasmussen, Executive Director General of Danish Veterinary and F2013/9/23
-
CFDA Assistant Minister Bian Zhenjia attends the Fourth China International Medical Device Regulatory ForumThe Fourth China International Medical Device Regulatory Forum opened in Xi’an on September 11, 2013. Bian Zhenjia, Assistant Minister of China Food and Drug Administration (CFDA), attended the openin2013/9/23
-
Glaxo, Roche, J&J and others score backing on big day for EU regulatorFriday, the EU's Committee for Medicinal Products for Human Use (CHMP) recommended 11 new drugs for a variety of diseases--the most nods it's given in a single meeting all year. Johnson & Johnson2013/9/22
-
Roche's new star Kadcyla picks up EU nodPricey drug looks to be powering on Roche's cancer drugKadcyla, an expected superstar that is pegged to assume the mantle of Herceptin in later years, has moved forward in Europe where Friday it was2013/9/22
-
Years after J&J recall, Sanofi unit brings Rolaids back to storesThree years ago, Johnson & Johnson ($JNJ) pulled Rolaids antacid products off the market, on fears that wood and metal particles had made their way into the tablets. Now, Sanofi's ($SNY) Chattem u2013/9/18
-
Congressman rails at Pfizer over problems with sarin gas antidoteSmall numbers of injectors don't have correct amount of protection When Pfizer ($PFE) picked upKing Pharmaceuticalsthree years ago, it cited the company's work with the Department of Defense as one a2013/9/18
-
CFDA Vice Minister Yin Li and Vice Minister Teng Jiacai meet with Minister of Food Industry of CubaOn September 16, 2013, China Food and Drug Administration (CFDA) Vice Minister Yin Li and CFDA Vice Minister Teng Jiacai respectively met with the delegation led by María del Carmen Concepción Gonzále2013/9/17